Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had ~~45,897,315~~45,898,111 shares of common stock, par value $0.001, outstanding as of ~~December 5, 2022.~~March 7, 2023.

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

Smith & Wesson®, S&W®, M&P®, M&P Shield®, Performance Center®, Airlite®, Airweight®, American Guardians®, America’s Master Gunmaker®, Armornite®, Arrow®, Aurora®, Aurora-II®, Blast Jacket®, Bodyguard®, Carry Comp®, Chiefs Special®, Club 1852®, Compass®, Competitor®, Contender®, CSX®, Dagger®, Dimension®, Encore®, E-Series®, EZ®, Flextech®, G-Core®, Gemtech®, Gemtech Suppressors®, Gemtech World-Class Silencers®, GM®, GMT-Halo®, Governor®, Integra®, Lady Smith®, Lever Lock®, ~~LOC®~~LOC Locking Optimized Components®, Lunar®, M2.0®, Mag Express®, Magnum®, Maxi-Hunter®, Mist-22®, Mountain Gun®, Number 13®, PC®, Power Rod®, Protected by Smith & Wesson®, Put A Legend On Your Line®, QLA®, Quick Load Accurizer®, Quickmount®, Shield®, Smith & Wesson Collectors Association®, Smith & Wesson Performance Center®, Smith & Wesson Precision Components®, Speed Breech®, Speed Breach XT®, SW22 Victory®, Swing Hammer®, T/C®, T/CR22®, T17®, The Professional’s Choice for Decades®, The S&W Bench®, The Sigma Series®, Thompson/Center®, Trek®, Triumph®, U-View®, Viper®, and Weather Shield® are some of the registered U.S. trademarks of our company or one of our subsidiaries. Abyss™, Neutron™, GVAC™, TEMPO™, OXBOW™, ETM™, FlexMag™, Silence Is Golden™, Smith & Wesson Response™, Smith & Wesson Academy™, M&P FPC™, C.O.R.E.™, SW Equalizer™, GM-S1™, Redux™, Oath™, Nerve™, Empowering Americans™, GunSmarts™, S&W500™~~, SD™~~, SDVE™, SW1911™, Volunteer™, Cheap Shot™, Impact!™, Impact!SB™, Katahdin™, Maxi-Ball™, Natural Lube 1000 Plus™, Pro Hunter™, Pro-Hunter FX™, Pro Hunter XT™, Quickshot™, Speed Shots™, Strike™, Super Glide™, Venture™, Alpine™, One™, Patrolman™, and Tracker™ are some of the unregistered trademarks of our company or one of our subsidiaries. This report also may contain trademarks and trade names of other companies.

The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained or incorporated herein by reference in this Quarterly Report on Form 10-Q, including statements regarding our future operating results, future financial position, business strategy, objectives, goals, plans, prospects, markets, and plans and objectives for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “targets,” “contemplates,” “projects,” “predicts,” “may,” “might,” “plan,” “will,” “would,” “should,” “could,” “may,” “can,” “potential,” “continue,” “objective,” or the negative of those terms, or similar expressions intended to identify forward-looking statements. However, not all forward-looking statements contain these identifying words. Specific forward-looking statements in this Quarterly Report on Form 10-Q include statements ~~that we plan~~regarding plans to move our headquarters and ~~certain~~significant of our manufacturing operations to a new facility being constructed in Maryville, Tennessee; lease payments for future periods; estimated amortization expense of intangible assets for future periods; our intention to terminate the Sublease (as defined herein) on or around the effective date of the Assignment and Assumption Agreement (as defined herein); negotiations with our lenders to transition from LIBOR to SOFR affecting our future borrowing rates; the outcome of the lawsuits to which we are subject and their effect on us; our belief that the claims asserted by Gemini (as defined herein) and plaintiffs in a putative class action against us have no merit and that we intend to aggressively defend these actions; our belief with respect to certain matters described in the Commitments and Contingencies – Litigation section, that the allegations are unfounded and that any incident and any results from them or any injuries were due to negligence or misuse of the firearm by the claimant or a third party; our belief that our accruals for product liability cases and claims are a reasonable quantitative measure of the cost to us of product liability cases and claims; our belief that we have provided adequate accruals for defense costs; our intention in connection with the Project Agreement (as defined herein) to incur, or cause to be incurred, no less than $120.0 million in aggregate capital expenditures on or before December 31, 2025, create no less than 620 new jobs, and sustain an average hourly wage of at least $25.97 at the facility; our intention, as part of the Relocation (as defined herein), to vacate and sublease our Missouri distribution facility; our belief that we will not incur an impairment associated with the lease associated with our Missouri distribution facility; our intention, with respect to assets associated with our assembly operations in Massachusetts and distribution operations in Missouri, to either move those assets to Tennessee at the appropriate time or sell or sublease those assets that will not be moved; our expectation that subsequent to the Relocation, our Massachusetts facility will continue to remain an important part of our manufacturing activities with significant portions of the operations being unaffected by the Relocation; our intention, at or near the conclusion of our Connecticut building lease in May 2024, to relocate a portion of the plastic injection molding operations to Tennessee and evaluate selling the remaining molding operations utilized in our Connecticut operations to a third party; our expectation to incur capital expenditures in connection with the construction and equipping of the new facility in Maryville, Tennessee in an aggregate amount of no less than $120.0 million on or before December 31, 2025; our belief that overall firearm demand remains healthy, as indicated by recent adjusted NICS data; our belief that the impact of inflation on consumer purchase power has resulted in a temporary shift toward lower priced offerings; our inventory levels, both internally and in the distribution channel, in excess of demand may negatively impact future operating results; our ability to utilize process improvements to mitigate inflationary impacts in future periods will likely resume only once the Relocation is completed; our expectation that our inventory levels will decline by the end of the fiscal year due to normal seasonality, but will remain elevated as we begin our transition to our new facility in Tennessee; our belief that overall firearm demand remains healthy, as indicated by recent adjusted NICS data; our expectation to incur capital expenditures in connection with the construction and equipping of the new facility in Maryville, Tennessee in an aggregate amount of approximately $160.0 million to $170.0 million through the end of fiscal 2024; our expectation for capital expenditures in fiscal 2023, including spending related to the Relocation; factors affecting our future capital requirements; availability of equity or debt financing on acceptable terms, if at all; the record date and payment date for our dividend; and our belief that our existing capital resources and credit facilities will be adequate to fund our operations, including our finance leases and other commitments, for the next 12 months. All forward-looking statements included herein are based on information available to us as of the date hereof and speak only as of such date. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. The forward-looking statements contained in or incorporated by reference into this Quarterly Report on Form 10-Q reflect our views as of the date hereof about future events and are subject to risks, uncertainties, assumptions, and changes in circumstances that may cause our actual results, performance, or achievements to differ significantly from those expressed or implied in any forward-looking statement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, performance, or achievements. A number of factors could cause actual results to differ materially from those indicated by the forward-looking statements. Such factors include, among other, economic, social, political, legislative, and regulatory factors; the potential for increased regulation of firearms and firearm-related products; actions of social activists that could have an adverse effect on our business; the impact of lawsuits; the demand for our products; the state of the U.S. economy in general and the firearm industry in particular; general economic conditions and consumer spending patterns, including the impact of inflationary pressures; our competitive environment; the supply, availability, and costs of raw materials and components; speculation surrounding fears of terrorism and crime; our anticipated growth and growth opportunities; our ability to effectively manage and execute the Relocation; our ability to increase demand for our products in various markets, including consumer, law enforcement, and military channels, domestically and internationally; our penetration rates in new and existing markets; our strategies; our ability to maintain and enhance brand recognition and reputation; our ability to introduce new products; the success of new products; our ability to expand our markets; our ability to integrate acquired businesses in a successful manner; the potential for cancellation of orders from our backlog; and other factors detailed from time to time in our reports filed with the Securities and Exchange Commission, or the SEC, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2022, or the Fiscal 2022 Form 10-K.


		As of:							As of:
		October 31, 2022			April 30, 2022				January 31, 2023			April 30, 2022
		(In thousands, except par value and share data)							(In thousands, except par value and share data)
ASSETS	ASSETS							ASSETS
Current assets:
Cash and cash equivalents		$	42,975		$	120,728			$	44,596		$	120,728
Accounts receivable, net of allowances for credit losses of $24 on October 31, 2022 and $36 on April 30, 2022			44,384			62,695
Accounts receivable, net of allowances for credit losses of $35 on January 31, 2023 and $36 on April 30, 2022										58,252			62,695
Inventories			196,474			136,660				193,426			136,660
Prepaid expenses and other current assets			8,062			5,569				5,954			5,569
Income tax receivable			10,988			1,945				7,660			1,945
Total current assets			302,883			327,597				309,888			327,597
Property, plant, and equipment, net			169,265			135,591				186,190			135,591
Intangibles, net			3,688			3,608				3,594			3,608
Goodwill			19,024			19,024				19,024			19,024
Deferred income taxes			1,221			1,221				1,221			1,221
Other assets			9,914			10,435				9,276			10,435
Total assets		$	505,995		$	497,476			$	529,193		$	497,476
LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY							LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	45,178		$	30,042			$	37,761		$	30,042
Accrued expenses and deferred revenue			23,845			23,482				19,485			23,482
Accrued payroll and incentives			17,042			17,371				18,444			17,371
Accrued income taxes			161			2,673				169			2,673
Accrued profit sharing			5,628			13,543				7,807			13,543
Accrued warranty			1,708			1,838				1,682			1,838
Total current liabilities			93,562			88,949				85,348			88,949
Notes and loans payable, net of current portion (Note 4)										24,769			—
Finance lease payable, net of current portion			37,013			37,628				36,687			37,628
Other non-current liabilities			8,780			10,385				8,021			10,385
Total liabilities			139,355			136,962				154,825			136,962
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized, no shares issued or outstanding			—			—				—			—
Common stock, $0.001 par value, 100,000,000 shares authorized, 74,934,815 issued and 45,894,445 shares outstanding on October 31, 2022 and 74,641,439 shares issued and 45,601,069 shares outstanding on April 30, 2022			75			75
Common stock, $0.001 par value, 100,000,000 shares authorized, 74,938,481 issued and 45,898,111 shares outstanding on January 31, 2023 and 74,641,439 shares issued and 45,601,069 shares outstanding on April 30, 2022										75			75
Additional paid-in capital			280,420			278,101				281,659			278,101
Retained earnings			508,447			504,640				514,936			504,640
Accumulated other comprehensive income			73			73				73			73
Treasury stock, at cost (29,040,370 shares on October 31, 2022 and April 30, 2022)			(422,375	)		(422,375	)
Treasury stock, at cost (29,040,370 shares on January 31, 2023 and April 30, 2022)										(422,375	)		(422,375	)
Total stockholders’ equity			366,640			360,514				374,368			360,514
Total liabilities and stockholders' equity		$	505,995		$	497,476			$	529,193		$	497,476

The accompanying notes are an integral part of these condensed consolidated financial statements.


	For the Three Months Ended October 31,						For the Six Months Ended October 31,						For the Three Months Ended January 31,						For the Nine Months Ended January 31,
	2022			2021			2022			2021			2023			2022			2023			2022
	(In thousands, except per share data)												(In thousands, except per share data)
Net sales	$	121,035		$	230,479		$	205,429		$	505,088		$	129,036		$	177,738		$	334,465		$	682,826
Cost of sales		81,773			128,484			134,696			273,151			87,195			107,339			221,890			380,490
Gross profit		39,262			101,995			70,733			231,937			41,841			70,399			112,575			302,336
Operating expenses:
Research and development		1,869			1,744			3,542			3,552			2,133			1,716			5,675			5,269
Selling, marketing, and distribution		9,431			11,423			17,458			22,057			9,996			11,518			27,454			33,575
General and administrative		15,435			23,436			33,288			41,049			15,576			17,443			48,867			58,491
Total operating expenses		26,735			36,603			54,288			66,658			27,705			30,677			81,996			97,335
Operating income		12,527			65,392			16,445			165,279			14,136			39,722			30,579			205,001
Other income/(expense), net:
Other income/(expense), net		790			833			1,463			1,493			840			751			2,304			2,244
Interest expense, net		(420	)		(466	)		(854	)		(1,011	)		(508	)		(594	)		(1,361	)		(1,605	)
Total other income/(expense), net		370			367			609			482			332			157			943			640
Income from operations before income taxes		12,897			65,759			17,054			165,761			14,468			39,879			31,522			205,641
Income tax expense		3,249			14,824			4,094			37,944			3,389			9,337			7,483			47,281
Net income	$	9,648		$	50,935		$	12,960		$	127,817		$	11,079		$	30,542		$	24,039		$	158,359
Net income per share:
Basic - net income	$	0.21		$	1.06		$	0.28		$	2.65		$	0.24		$	0.65		$	0.52		$	3.32
Diluted - net income	$	0.21		$	1.05		$	0.28		$	2.63		$	0.24		$	0.65		$	0.52		$	3.28
Weighted average number of common shares outstanding:
Basic		45,815			48,147			45,777			48,270			45,897			46,763			45,817			47,769
Diluted		46,106			48,692			46,104			48,524			46,166			47,175			46,133			48,307

The accompanying notes are an integral part of these condensed consolidated financial statements.


											Accumulated																				Accumulated
	Common				Additional						Other							Total			Common				Additional						Other							Total
	Stock				Paid-In			Retained			Comprehensive		Treasury Stock					Stockholders’			Stock				Paid-In			Retained			Comprehensive		Treasury Stock					Stockholders’
(In thousands)	Shares		Amount		Capital			Earnings			Income		Shares		Amount			Equity			Shares		Amount		Capital			Earnings			Income		Shares		Amount			Equity
Balance at July 31, 2021		74,298	$	74	$	274,068		$	398,219		$	73		26,252	$	(372,375	)	$	300,059
Balance at October 31, 2021																						74,547	$	75	$	275,229		$	445,306		$	73		26,252	$	(372,375	)	$	348,308
Stock-based compensation		—		—		914			—			—		—		—			914			—		—		1,199			—			—		—		—			1,199
Shares issued under employee stock purchase plan		61		—		831			—			—		—		—			831			—		—		15			—			—		—		—			15
Issuance of common stock under restricted stock unit awards, net of shares surrendered		188		1		(584	)		—			—		—		—			(583	)		3		—		(54	)		—			—		—		—			(54	)
Repurchase of treasury stock																						—		—		—			—			—		2,788		(50,000	)		(50,000	)
Dividends issued	—		—		—				(3,848	)	—		—		—				(3,848	)		—		—		—			(3,701	)		—		—		—			(3,701	)
Net income		—		—	—				50,935			—		—		—			50,935			—		—	—				30,542			—		—		—			30,542
Balance at October 31, 2021		74,547		75		275,229			445,306			73		26,252		(372,375	)		348,308
Balance at January 31, 2022																						74,550		75		276,389			472,147			73		29,040		(422,375	)		326,309

Balance at April 30, 2021		74,222		74		273,431			325,181			73		24,285		(332,375	)		266,384			74,222		74		273,431			325,181			73		24,285		(332,375	)		266,384
Stock-based compensation		—		—		2,366			—			—		—		—			2,366			—		—		3,565			—			—		—		—			3,565
Shares issued under employee stock purchase plan		61		—		831			—			—		—		—			831			61		—		846			—			—		—		—			846
Issuance of common stock under restricted stock unit awards, net of shares surrendered		264		1		(1,399	)		—			—		—		—			(1,398	)		267		1		(1,453	)		—			—		—		—			(1,452	)
Repurchase of treasury stock	—		—		—			—			—			1,967		(40,000	)		(40,000	)	—		—		—			—			—			4,755		(90,000	)		(90,000	)
Dividends issued	—		—		—				(7,692	)	—		—		—				(7,692	)	—		—		—				(11,393	)	—		—		—				(11,393	)
Net income		—		—	—				127,817			—		—		—			127,817			—		—	—				158,359			—		—		—			158,359
Balance at October 31, 2021		74,547		75		275,229			445,306			73		26,252		(372,375	)		348,308
Balance at January 31, 2022																						74,550		75		276,389			472,147			73		29,040		(422,375	)		326,309

Balance at July 31, 2022		74,811		75		278,297			503,376			73		29,040		(422,375	)		359,446
Balance at October 31, 2022																						74,935		75		280,420			508,447			73		29,040		(422,375	)		366,640
Stock-based compensation		—		—		1,428			—			—		—		—			1,428			—		—		1,253			—			—		—		—			1,253
Shares issued under employee stock purchase plan		85		—		753			—			—		—		—			753
Issuance of common stock under restricted stock unit awards, net of shares surrendered		39		—		(58	)		—			—		—		—			(58	)		3		—		(14	)		—			—		—		—			(14	)
Dividends issued	—		—		—				(4,577	)	—		—		—				(4,577	)	—		—			—			(4,590	)	—		—		—				(4,590	)
Net income		—		—	—				9,648			—		—		—			9,648			—		—	—				11,079			—		—		—			11,079
Balance at October 31, 2022		74,935		75		280,420			508,447			73		29,040		(422,375	)		366,640
Balance at January 31, 2023																						74,938		75		281,659			514,936			73		29,040		(422,375	)		374,368

Balance at April 30, 2022		74,641		75		278,101			504,640			73		29,040		(422,375	)		360,514			74,641		75		278,101			504,640			73		29,040		(422,375	)		360,514
Stock-based compensation		—		—		2,605			—			—		—		—			2,605			—		—		3,859			—			—		—		—			3,859
Shares issued under employee stock purchase plan		85		—		753			—			—		—		—			753			85		—		753			—			—		—		—			753
Issuance of common stock under restricted stock unit awards, net of shares surrendered		209		—		(1,039	)		—			—		—		—			(1,039	)		212		—		(1,054	)		—			—		—		—			(1,054	)
Dividends issued	—		—		—				(9,153	)	—		—		—				(9,153	)	—		—		—				(13,744	)	—		—		—				(13,744	)
Net income		—		—	—				12,960			—		—		—			12,960			—		—	—				24,039			—		—		—			24,039
Balance at October 31, 2022		74,935	$	75	$	280,420		$	508,447		$	73		29,040	$	(422,375	)	$	366,640
Balance at January 31, 2023																						74,938	$	75	$	281,659		$	514,936		$	73		29,040	$	(422,375	)	$	374,368

The accompanying notes are an integral part of these condensed consolidated financial statements.


	For the Six Months Ended October 31,						For the Nine Months Ended January 31,
	2022			2021			2023			2022
	(In thousands)						(In thousands)
Cash flows from operating activities:
Net income	$	12,960		$	127,817		$	24,039		$	158,359
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		15,171			15,210			21,795			22,413
(Gain)/loss on sale/disposition of assets		(43	)		57			(43	)		31
Provision for (recoveries)/losses on notes and accounts receivable		(13	)		781			(1	)		678
Impairment of long-lived tangible assets		—			86			—			86
Stock-based compensation expense		2,605			2,366			3,859			3,565
Changes in operating assets and liabilities:
Accounts receivable		18,324			22,435			4,444			17,378
Inventories		(59,814	)		(41,800	)		(56,767	)		(55,791	)
Prepaid expenses and other current assets		(2,493	)		87			(384	)		887
Income taxes		(11,555	)		(243	)		(8,220	)		(2,119	)
Accounts payable		5,889			(8,514	)		134			(21,209	)
Accrued payroll and incentives		(329	)		(6,313	)		1,073			(1,158	)
Accrued profit sharing		(7,915	)		(6,668	)		(5,737	)		(2,943	)
Accrued expenses and deferred revenue		307			(1,205	)		(4,078	)		(6,322	)
Accrued warranty		(130	)		(57	)		(156	)		(159	)
Other assets		521			2,030			1,158			2,188
Other non-current liabilities		(1,650	)		(705	)		(2,364	)		(3,609	)
Net cash (used in)/provided by operating activities		(28,165	)		105,364			(21,248	)		112,275
Cash flows from investing activities:
Payments to acquire patents and software		(256	)		(156	)		(251	)		(218	)
Proceeds from sale of property and equipment		85			70			85			97
Payments to acquire property and equipment		(39,419	)		(10,113	)		(64,586	)		(15,090	)
Net cash used in investing activities		(39,590	)		(10,199	)		(64,752	)		(15,211	)
Cash flows from financing activities:
Proceeds from loans and notes payable								25,000			—
Payments on finance lease obligation		(559	)		(531	)		(856	)		(813	)
Payments on notes and loans payable								(231	)		—
Payments to acquire treasury stock		—			(40,000	)		—			(90,000	)
Dividend distribution		(9,153	)		(7,692	)		(13,744	)		(11,393	)
Proceeds from exercise of options to acquire common stock, including employee stock purchase plan		753			831			753			846
Payment of employee withholding tax related to restricted stock units		(1,039	)		(1,399	)		(1,054	)		(1,453	)
Net cash used in financing activities		(9,998	)		(48,791	)
Net (decrease)/increase in cash and cash equivalents		(77,753	)		46,374
Net cash provided by/(used in) financing activities								9,868			(102,813	)
Net decrease in cash and cash equivalents								(76,132	)		(5,749	)
Cash and cash equivalents, beginning of period		120,728			113,017			120,728			113,017
Cash and cash equivalents, end of period	$	42,975		$	159,391		$	44,596		$	107,268
Supplemental disclosure of cash flow information
Cash paid for:
Interest	$	1,089		$	1,116		$	1,743		$	1,670
Income taxes	$	15,721		$	38,186		$	15,775		$	49,402

The accompanying notes are an integral part of these condensed consolidated financial statements.

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

(3) Leases:

We lease certain of our real estate, machinery, and equipment under non-cancelable operating lease agreements.

We recognize expenses under our operating lease assets and liabilities at the lease commencement date based on the present value of lease payments over the lease term. Our leases do not provide an implicit interest rate. We use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Our lease agreements do not require material variable lease payments, residual value guarantees, or restrictive covenants. For operating leases, we recognize expense on a straight-line basis over the lease term. We record tenant improvement allowances as an offsetting adjustment included in our calculation of the respective right-of-use asset.

Certain of our leases include renewal options that enable us to extend the lease term. The execution of those renewal options is at our sole discretion and are reflected in the lease term when they are reasonably certain to be exercised. The depreciable life of assets and leasehold improvements are limited by the expected lease term.

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

The amounts of assets and liabilities related to our operating and financing leases as of ~~October~~January 31, ~~2022~~2023 were as follows (in thousands):


	Balance Sheet Caption	October 31, 2022			Balance Sheet Caption	January 31, 2023
Operating Leases
Right-of-use assets		$	7,297			$	7,297
Accumulated amortization			(4,393	)			(4,780	)
Right-of-use assets, net	Other assets	$	2,904		Other assets	$	2,517

Current liabilities	Accrued expenses and deferred revenue	$	1,619		Accrued expenses and deferred revenue	$	1,596
Non-current liabilities	Other non-current liabilities		1,525		Other non-current liabilities		1,153
Total operating lease liabilities		$	3,144			$	2,749
Finance Leases
Right-of-use assets		$	40,986			$	40,761
Accumulated depreciation			(7,381	)			(7,839	)
Right-of-use assets, net	Property, plant, and equipment, net	$	33,605		Property, plant, and equipment, net	$	32,922

Current liabilities	Accrued expenses and deferred revenue	$	1,214		Accrued expenses and deferred revenue	$	1,243
Non-current liabilities	Finance lease payable, net of current portion		37,013		Finance lease payable, net of current portion		36,687
Total finance lease liabilities		$	38,227			$	37,930

For the three months ended ~~October~~January 31, ~~2022,~~2023, we recorded $~~462,000~~467,000 of operating lease costs, of which $~~21,000~~27,000 related to short-term leases that were not recorded as right-of-use assets. We recorded $523,000 of financing lease amortization and $~~480,000~~477,000 of financing lease interest expense for the three months ended ~~October~~January 31, ~~2022.~~2023. For the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we recorded $~~909,000~~1.4 million of operating lease costs, of which $~~51,000~~78,000 related to short-term leases that were not recorded as right-of-use assets. We recorded $~~1.0~~1.6 million of financing lease amortization and $~~964,000~~1.4 million of financing lease interest expense for the ~~six~~nine months ended ~~October~~January 31, ~~2022.~~2023. As of ~~October~~January 31, ~~2022,~~2023, our weighted average lease term and weighted average discount rate for our operating leases were ~~2.8~~2.7 years and 4.4%, respectively. As of ~~October~~January 31, ~~2022,~~2023, our weighted average lease term and weighted average discount rate for our financing leases were ~~16.0~~15.8 years and 5.0%, respectively, and consisted primarily of our Missouri distribution ~~facility.~~center. The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight-line basis over the life of the lease.

On October 26, 2017, we entered into (a) a lease agreement with Ryan Boone County, LLC, or the Original MO Landlord, concerning certain real property located in Boone County, Missouri on which we have been operating our distribution center, or the MO Lease, and (b) a guaranty in favor of the Original MO Landlord, or the Guaranty. With the completion of the spin-off of our outdoor products and accessories business on August 24, 2020, or the Separation, we entered into a sublease whereby American Outdoor Brands, Inc., our former wholly owned subsidiary, or AOUT, subleases from us 59.0% of our Missouri distribution ~~facility~~center under the same terms as the ~~master lease.~~MO Lease, or the Sublease. On July 16, 2022, we entered into an amendment to the ~~sublease agreement,~~Sublease, increasing the leased space to 64.7% of the facility under the same terms as the ~~master lease.~~MO Lease. On January 31, 2023, we entered into (i) an assignment and assumption agreement with AOUT, pursuant to which AOUT will assume all of our rights, entitlement, and obligations in, to, and under the MO Lease, in each case effective on January 1, 2024, subject to a number of conditions precedent, or the Assignment and Assumption Agreement, and (ii) an amended and restated guaranty in favor of RCS-S&W Facility, LLC, as successor in interest to the Original MO Landlord, pursuant to which Smith & Wesson Sales Company was added as a guarantor, or the Amended and Restated Guaranty. We intend to terminate the Sublease on or around the effective date of the Assignment and Assumption Agreement. For the three and ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, income related to ~~this sublease~~the Sublease was $~~565,000~~579,000 and $~~1.1~~1.7 million, respectively, which was recorded in other income in our condensed consolidated statements of income.

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and Nine Months Ended January 31, 2023 and 2022

The following table represents future expected undiscounted cashflows, based on the sublease agreement with AOUT, to be received on an annual basis for the next five years and thereafter, as of ~~October~~January 31, ~~2022~~2023 (in thousands):


Fiscal	Amount			Amount
2023	$	1,033		$	518
2024		2,086			2,435
2025		2,123			3,180
2026		2,160			3,235
2027		2,198			3,292
Thereafter		28,658			42,256
Total future sublease receipts		38,258			54,916
Less amounts representing interest		(10,002	)		(17,274	)
Present value of sublease receipts	$	28,256		$	37,642

~~SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~For the Three and Six Months Ended October 31, 2022 and 2021~~

Future lease payments for all our operating and finance leases for succeeding fiscal years is as follows (in thousands):


	Operating			Financing			Total			Operating			Financing			Total
2023	$	889		$	1,549		$	2,438		$	444		$	775		$	1,219
2024		1,650			3,125			4,775			1,650			3,125			4,775
2025		324			3,180			3,504			324			3,180			3,504
2026		301			3,235			3,536			301			3,235			3,536
2027		272			3,292			3,564			272			3,292			3,564
Thereafter		125			42,256			42,381			125			42,256			42,381
Total future lease payments		3,561			56,637			60,198			3,116			55,863			58,979
Less amounts representing interest		(417	)		(18,410	)		(18,827	)		(367	)		(17,933	)		(18,300	)
Present value of lease payments		3,144			38,227			41,371			2,749			37,930			40,679
Less current maturities of lease liabilities		(1,619	)		(1,214	)		(2,833	)		(1,596	)		(1,243	)		(2,839	)
Long-term maturities of lease liabilities	$	1,525		$	37,013		$	38,538		$	1,153		$	36,687		$	37,840

For the three and ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, the cash paid for amounts included in the measurement of the liabilities and the operating cash flows was $1.2 million and $~~2.2~~3.7 million, respectively.

(8) Stockholders’ Equity:

~~Treasury Stock~~

~~On March 2, 2021, our Board of Directors authorized the repurchase of up to $100.0~~ ~~million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. During fiscal 2021, we repurchased~~ ~~3,380,447~~ ~~shares of our common stock for $60.0~~ ~~million under this authorization. During the six months ended October 31, 2021, we completed this stock repurchase program by repurchasing~~ ~~1,967,420~~ ~~shares of our common stock for $40.0~~ ~~million, utilizing cash on hand. On June 15, 2021, our Board of Directors authorized the repurchase of an additional $50.0~~ million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. For the six months ended October 31, 2021, there were no purchases under this authorization; however, this authorization was completed during fiscal 2022. There were no common stock purchases through the six months ended October 31, 2022, nor were there any unfulfilled authorizations.

Earnings per Share

The following table provides a reconciliation of net income and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (in thousands, except per share data):


	For the Three Months Ended October 31,																For the Three Months Ended January 31,
	2022								2021								2023								2022
	Net					Per Share			Net					Per Share			Net					Per Share			Net					Per Share
	Income			Shares		Amount			Income			Shares		Amount			Income			Shares		Amount			Income			Shares		Amount
Basic earnings	$		9,648		45,815	$		0.21	$		50,935		48,147	$	1.06		$		11,079		45,897	$		0.24	$		30,542		46,763	$		0.65
Effect of dilutive stock awards		—			291		—			—			545		(0.01	)		—			269		—			—		412			—
Diluted earnings	$		9,648		46,106	$		0.21	$		50,935		48,692	$	1.05		$		11,079		46,166	$		0.24	$		30,542		47,175	$		0.65

The following table provides a reconciliation of net income and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (in thousands, except per share data):

For the Six Months Ended October 31,

2022

2021

Net

Per Share

Net

Per Share

Income

Shares

Amount

Income

Shares

Amount

Basic earnings
$

12,960

45,777

$

0.28

$

127,817

48,270

$

2.65

Effect of dilutive stock awards

—

327

—

—

254

(0.02
)
Diluted earnings
$

12,960

46,104

$

0.28

$

127,817

48,524

$

2.63


	For the Nine Months Ended January 31,
	2023								2022
	Net					Per Share			Net					Per Share
	Income			Shares		Amount			Income			Shares		Amount
Basic (loss)/earnings	$		24,039		45,817	$		0.52	$		158,359		47,769	$		3.32
Effect of dilutive stock awards		—		316			—			—		538			—
Diluted (loss)/earnings	$		24,039		46,133	$		0.52	$		158,359		48,307	$		3.28

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

For the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, the amount of restricted stock units, or RSUs, excluded from the computation of diluted earnings per share was ~~23,264~~16,677 and ~~17,815~~11,739, respectively, because the effect would be antidilutive. For the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, the amount of shares excluded from the computation of diluted earnings per share was ~~25,730~~21,157 and ~~25,036~~22,720, respectively, because the effect would be antidilutive.

Incentive Stock and Employee Stock Purchase Plans

We have two stock plans: the 2013 Incentive Stock Plan and the 2022 Incentive Stock Plan. New grants under the 2013 Incentive Stock Plan have not been made since our stockholders approved the 2022 Incentive Stock Plan at our annual meeting of stockholders held on September 12, 2022. All new grants covering participants are issued under the 2022 Incentive Stock Plan.

The 2022 Incentive Stock Plan authorizes the issuance of 1,000,000 shares, plus any shares that were reserved and remained available for grant and delivery under the 2013 Incentive Stock Plan as of September 12, 2022, the effective date of the 2022 Incentive Stock Plan. The 2022 Incentive Stock Plan permits the grant of options to acquire common stock, restricted stock awards, RSUs, stock appreciation rights, bonus stock and awards in lieu of obligations, performance awards, and dividend equivalents. Our Board of Directors, or a committee, ~~established by our board,~~ administers the stock plans, selects recipients to whom awards are granted, and determines the grants to be awarded. Options granted under the stock plans are exercisable at a price determined by our Board of Directors or a committee at the time of grant, but in no event, less than fair market value of our common stock on the effective date ~~granted.~~of the grant. Grants of options may be made to employees and directors without regard to any performance measures. All options issued pursuant to the stock plans are generally nontransferable and subject to forfeiture.

Unless terminated earlier by our Board of Directors, the 2022 Incentive Stock Plan will terminate at the earliest of (1) the tenth anniversary of the effective date of the 2022 Incentive Stock Plan, or (2) such time as no shares of common stock remain available for issuance under the plan and we have no further rights or obligations with respect to outstanding awards under the plan. The date of grant of an award is deemed to be the effective date upon which our Board of Directors or a committee authorizes the granting of such award.

Except in specific circumstances, grants vest over a period of four years and grants of stock options are exercisable for a period of 10 years. The 2022 Incentive Stock Plan also permits the grant of awards to non-employees, which our Board of Directors or a committee has authorized in the past.

We have an Employee Stock Purchase Plan, or the ESPP, under which each participant is granted an option to purchase our common stock at a discount on each subsequent exercise date during the offering period (as such terms are defined in the ESPP) in accordance with the terms of the ESPP.

The total stock-based compensation expense, including stock options, purchases under our ESPP, RSUs, and performance-based RSUs, or PSUs, was $~~2.6~~3.9 million and $~~2.4~~3.6 million for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, respectively. We include stock-based compensation expense in cost of sales, sales and marketing, research and development, and general and administrative expenses.

We grant RSUs to employees and non-employee members of our Board of Directors. The awards are made at no cost to the recipient. An RSU represents the right to receive one share of our common stock and does not carry voting or dividend rights. Except in specific circumstances, RSU grants to employees vest over a period of four years with one-fourth of the units vesting on each anniversary of the grant date. We amortize the aggregate fair value of our RSU grants to compensation expense over the vesting period.

We grant PSUs to our executive officers and, from time to time, certain management employees who are not executive officers. The PSUs vest, and the fair value of such PSUs will be recognized, over the corresponding three-year performance period.

During the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we granted an aggregate of 286,218 RSUs, including 157,227 RSUs to non-executive officer employees, 7~~2,494~~72,494 RSUs to our executive officers, and 56,497 RSUs to our directors. During the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we granted 108,736 PSUs to certain of our executive officers. During the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we cancelled ~~3,996~~33,974 RSUs as a result of the service conditions not being met. In connection with the vesting of RSUs, during the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we delivered common stock to our employees and directors, including our executive officers, with a total market value of $3.9 million. In connection with a 2018 grant, which vested in fiscal 2022, we delivered market-condition PSUs to certain of our executive officers and a former executive officer with a total market value of $1.2 million. In addition, in connection

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and Nine Months Ended January 31, 2023 and 2022

with a 2019 grant, 57,600 PSUs vested to certain of our executive officers and a former executive officer, which resulted from achieving the maximum performance of 200.0% of target for the original 28,800 PSUs granted.

~~SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~For the Three and Six Months Ended October 31, 2022 and 2021~~

During the ~~six~~nine months ended ~~October~~January 31, ~~2021,~~2022, we granted an aggregate of ~~158,420~~184,767 RSUs, including ~~66,441~~76,547 RSUs to non-executive officer employees, ~~49,277~~65,518 RSUs to our executive officers, and 42,702 RSUs to our directors. During the ~~six~~nine months ended ~~October~~January 31, ~~2021,~~2022, we granted 73,913 PSUs to certain of our executive officers. During the ~~six~~nine months ended ~~October~~January 31, ~~2021,~~2022, we cancelled 40,869 PSUs and ~~37,051~~44,529 RSUs as a result of the service conditions not being met. In connection with the vesting of RSUs, during the ~~six~~nine months ended ~~October~~January 31, ~~2021,~~2022, we delivered common stock to our employees and directors, including our executive officers, with a total market value of $~~6.9~~7.1 million. In addition, in connection with a 2018 grant, 86,400 PSUs vested to certain of our executive officers and a former executive officer, which resulted from achieving the maximum performance of 200.0% of target for the original 43,200 PSUs granted.

A summary of activity for unvested RSUs and PSUs for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 is as follows:


	For the Six Months Ended October 31,										For the Nine Months Ended January 31,
	2022					2021					2023					2022
				Weighted					Weighted					Weighted					Weighted
	Total # of			Average		Total # of			Average		Total # of			Average		Total # of			Average
	Restricted			Grant Date		Restricted			Grant Date		Restricted			Grant Date		Restricted			Grant Date
	Stock Units			Fair Value		Stock Units			Fair Value		Stock Units			Fair Value		Stock Units			Fair Value
RSUs and PSUs outstanding, beginning of period		827,930		$	13.30		995,879		$	10.65		827,930		$	13.30		995,879		$	11.65
Awarded (a)		423,754			13.53		275,533			17.08		423,754			13.53		301,880			16.54
Vested		(281,135	)		13.88		(329,726	)		12.42		(286,418	)		13.97		(336,920	)		14.61
Forfeited		(3,996	)		15.23		(77,920	)		11.49		(33,974	)		15.17		(85,398	)		15.19
RSUs and PSUs outstanding, end of period		966,553		$	13.22		863,766		$	11.96		931,292		$	13.13		875,441		$	11.13

——————————

(a)

Includes 28,800 and 43,200 PSUs that vested during the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, respectively, in connection with achieving maximum performance targets for the 2019 and 2018 grants, respectively.

As of ~~October~~January 31, ~~2022,~~2023, there was $~~5.3~~3.9 million of unrecognized compensation expense related to unvested RSUs and PSUs. This expense is expected to be recognized over a weighted average remaining contractual term of ~~1.5~~1.2 years.

(9) Commitments and Contingencies:

Litigation

In January 2018, Gemini Technologies, Incorporated, or Gemini, commenced an action against us in the U.S. District Court for the District of Idaho, or the District Court. The complaint alleges, among other things, that we breached the earn-out and other provisions of the asset purchase agreement and ancillary agreements between the parties in connection with our acquisition of the Gemtech business from Gemini. The complaint seeks a declaratory judgment interpreting various terms of the asset purchase agreement and damages in the sum of $18.6 million. In May 2018, the District Court dismissed the complaint on the grounds of forum non conveniens. In June 2018, Gemini appealed the decision dismissing its complaint to the U.S. Court of Appeals for the Ninth Circuit, or the Ninth Circuit. In July 2019, the Ninth Circuit reversed the dismissal and remanded the case to the District Court to perform a traditional forum non conveniens analysis. In September 2019, the parties stipulated that they do not contest that the venue is proper in the District of Idaho. In November 2019, we filed an answer to Gemini’s complaint and a counterclaim against Gemini and its stockholders at the time of the signing of the asset purchase agreement. Plaintiffs amended their complaint to add a claim of fraud in the inducement. In September 2021, Gemini filed a motion for summary judgment seeking to dismiss our counterclaim. In October 2021, we filed our opposition to Gemini’s motion. On June 27, 2022, the court denied Gemtech's motion for summary judgment. We believe the claims asserted in the complaint have no merit, and we intend to aggressively defend this action.

We are a defendant in ~~six~~five product liability cases and are aware of ~~five~~six other product liability claims, primarily alleging defective product design, defective manufacturing, or failure to provide adequate warnings. In addition, we are a co-defendant in a case filed in August 1999 by the city of Gary, Indiana, or the City, against numerous firearm manufacturers, distributors, and dealers seeking to recover monetary damages, as well as injunctive relief, allegedly arising out of the misuse of firearms by third parties. In January 2018, the Lake Superior Court, County of Lake, Indiana granted defendants’ Motion for Judgment on the Pleadings, dismissing the case in its entirety. In February 2018, plaintiffs appealed the dismissal to the Indiana Court of Appeals. In May 2019, the Indiana Court of Appeals issued a decision, which affirmed in part and reversed in part and remanded for further proceedings, the trial court’s dismissal of the City’s complaint. In July 2019, defendants filed a Petition to Transfer jurisdiction to the Indiana Supreme Court. In November 2019, the Indiana Supreme Court denied our petition to transfer and the case was returned to the trial court. Discovery remains ongoing.

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

City’s complaint. In July 2019, defendants filed a Petition to Transfer jurisdiction to the Indiana Supreme Court. In November 2019, the Indiana Supreme Court denied defendants' petition to transfer and the case was returned to the trial court. Discovery remains ongoing.

In May 2018, we were named in an action related to the Parkland, Florida shooting that was filed in the Circuit Court, Broward County, Florida seeking a declaratory judgment that a Florida statute that provides firearm manufacturers and dealers immunity from liability when their legally manufactured and lawfully sold firearms are later used in criminal acts applies only to civil actions commenced by governmental agencies, not private litigants. In August 2018, we moved to dismiss the complaint on the grounds that it seeks an impermissible advisory opinion. In December 2018, the court granted defendants’ motion to dismiss without prejudice and granted plaintiffs leave to amend their complaint. Later in December 2018, plaintiffs filed a Second Amended Complaint for Declaratory Relief and defendants filed a Motion to Dismiss Plaintiffs’ Second Amended Complaint. In November 2019, the court granted defendants’ motion to dismiss plaintiffs’ second amended complaint, with prejudice. In June 2021, upon plaintiffs’ motion, the Fourth District Court of Appeal of the State of Florida, or the Court of Appeal, ruled that the Circuit Court’s order dismissing the case was not “final and appealable” and ordered the Circuit Court to enter a final order of dismissal. In July 2021, certain plaintiffs ~~Frederic and Jennifer Guttenberg~~ filed a notice of appeal to the Court of Appeal. ~~Briefing in~~On January 4, 2023, the Court of Appeal ~~is complete. Oral argument was held on July 12, 2022. No decision has been issued~~affirmed the trial court's dismissal of the case. On February 6, 2023, plaintiffs filed a notice of appeal to ~~date.~~the Supreme Court of Florida.

We are a defendant in a putative class proceeding before the Ontario Superior Court of Justice in Toronto, Canada that was filed in December 2019. The action claims CAD$50 million in aggregate general damages, CAD$100 million in aggregate punitive damages, special damages in an unspecified amount, together with interest and legal costs. The named plaintiffs are two victims of a shooting that took place in Toronto in July 2018 and their family members. One victim was shot and injured during the shooting. The other victim suffered unspecified injuries while fleeing the shooting. The plaintiffs are seeking to certify a claim on behalf of classes that include all persons who were killed or injured in the shooting and their immediate family members. The plaintiffs allege negligent design and public nuisance. The case has not been certified as a class action. In July 2020, we filed a Notice of Motion for an order striking the claim and dismissing the action in its entirety. In February 2021, the court granted our motion in part, and dismissed the plaintiffs’ claims in public nuisance and strict liability. The court declined to strike the negligent design claim and ordered that the claim proceed to a certification motion. In March 2021, we filed a motion for leave to appeal the court’s refusal to strike the negligent design claim with the Divisional Court, Ontario Superior Court of Justice. In July 2021, plaintiffs filed a motion to stay our motion for leave to appeal with the Divisional Court, on grounds that appeal is premature. In November 2021, the Divisional Court granted plaintiffs' motion, staying our motion for leave to appeal until 30 days after the decision on the balance of plaintiffs' certification motion. Plaintiffs’ certification motion ~~which had been scheduled for December 2022, has been~~was extended by the court to ~~allow plaintiffs to file further evidence in support of certification.~~January 2024.

In May 2020, we were named in an action related to the Chabad of Poway synagogue shooting that took place in April 2019. The complaint was filed in the Superior Court of the State of California, for the County of San Diego – Central, and asserts claims against us for product liability, unfair competition, negligence, and public nuisance. The plaintiffs allege they were present at the synagogue on the day of the incident and suffered physical and/or emotional injury. The plaintiffs seek compensatory and punitive damages, attorneys’ fees, and injunctive relief. In September 2020, we filed a demurrer and motion to strike, seeking to dismiss plaintiffs’ complaint. In July 2021, the court granted our motion in part, and reversed it in part, ruling that (1) the PLCAA barred plaintiffs’ product liability action; (2) plaintiffs did not have standing to maintain an action under the Unfair Competition Law for personal injury related damages, but gave plaintiffs leave to amend to plead an economic injury; and (3) the PLCAA did not bar plaintiffs’ ordinary negligence and public nuisance actions because plaintiffs had alleged that we violated 18 U.S.C. Section 922(b)(4), which generally prohibits the sale of fully automatic “machineguns.” In August 2021, we filed a Petition for Writ of Mandate in the Court of Appeal of the ~~state~~State of California, Fourth Appellate District, Division One. In September 2021, the Court of Appeal denied our appeal. OnIn February ~~22,~~ 2022, the court consolidated the case with three related cases, in which we are not a party. OnIn March ~~11,~~ 2022, the court granted our motion, dismissing plaintiffs’ Unfair Competition Law claim, without further leave to amend. Discovery is ongoing.

We are a defendant in an action filed in the U.S. District Court for the District of Massachusetts. OnIn August 4, 2021, the Mexican Government filed an action against several U.S.-based firearms manufacturers and a firearms distributor, claiming defendants design, market, distribute, and sell firearms in ways they know routinely arm the drug cartels in Mexico. Plaintiff alleges, among other claims, negligence, public nuisance, design defect, unjust enrichment and restitution against all defendants and violation of the Massachusetts Consumer Protection Act against us alone, and is seeking monetary damages and injunctive relief. In November 2021, defendants filed motions to dismiss plaintiff's complaint. OnIn January ~~31,~~ 2022, plaintiff filed its oppositions to our motions. Several amicus briefs were also filed with the court. OnIn April ~~12,~~ 2022, a hearing was held on defendants’ motions to dismiss. OnIn September ~~30,~~ 2022, the district court granted defendants’ motions to dismiss. OnIn October ~~26,~~ 2022, plaintiff filed a notice of appeal with the U.S. Court of Appeals for the First Circuit.

WeIn September 2022, we were ~~recently~~ named as defendants in 12 nearly identical, separate actions related to a shooting in Highland Park, Illinois on July 4, 2022. The complaints were filed in the Circuit Court of the Nineteenth Judicial Circuit in Lake County, Illinois and ~~assert claims against us for negligence and for deceptive and unfair practices under the Illinois Consumer Fraud and Deceptive Business Practices~~

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022

assert claims against us for negligence and for deceptive and unfair practices under the Illinois Consumer Fraud and Deceptive Business Practices Act. Plaintiffs also name as defendants the website and retailer that sold the firearm, the shooter, and the shooter’s father. The plaintiffs allege they were present at a parade at the time of the incident and suffered physical and/or emotional injury. The plaintiffs seek compensatory damages, attorneys’ fees and injunctive relief. We filed motions for removal of each case to the U.S. District Court for the Northern District of Illinois. OnIn November ~~18,~~ 2022, we filed a motion to consolidate the cases for preliminary motion purposes. In December 2022, plaintiffs filed motions to remand the cases back to the state court. On January 20, 2023, we filed our opposition to plaintiffs’ motion to remand.

In December 2022, the City of Buffalo, New York filed a complaint in the Supreme Court of the State of New York, County of Erie, against numerous manufacturers, distributors, and retailers of firearms. Later in December 2022, the City of Rochester, New York filed an almost identical complaint in the Supreme Court of the State of New York, County of Monroe, against the same defendants. The complaints allege violation of New York General Business Law, public nuisance, and deceptive business practices in violation of NY General Business Laws. In January 2023, we filed notices of removal of the cases to the US District Court.

We believe that the various allegations as described above are unfounded, and, in addition, that any incident and any results from them or any injuries were due to negligence or misuse of the firearm by the claimant or a third party.

OnIn March 9, 2022, two plaintiffs, on behalf of a proposed class of current and former employees and temporary workers who worked at our Springfield facility from November 2018 to the present, filed a claim alleging non-payment of wages and overtime in violation of the Massachusetts Wage Act and Massachusetts Fair Wage Act. The case has not been certified as a class action. We believe the claims asserted in the complaint have no merit, and we intend to aggressively defend this action.

In addition, from time to time, we are involved in lawsuits, claims, investigations, and proceedings, including commercial, environmental, premises and employment matters, which arise in the ordinary course of business.

The relief sought in individual cases primarily includes compensatory and, sometimes, punitive damages. Certain of the cases and claims seek unspecified compensatory or punitive damages. In others, compensatory damages sought may range from less than $75,000 to approximately $50.0 million. In our experience, initial demands do not generally bear a reasonable relationship to the facts and circumstances of a particular matter. We believe that our accruals for product liability cases and claims are a reasonable quantitative measure of the cost to us of product liability cases and claims.

We are vigorously defending ourselves in the lawsuits to which we are subject. An unfavorable outcome or prolonged litigation could harm our business. Litigation of this nature also is expensive, time consuming, and diverts the time and attention of our management.

We monitor the status of known claims and the related product liability accrual, which includes amounts for defense costs for asserted and unasserted claims. After consultation with litigation counsel and a review of the merit of each claim, we have concluded that we are unable to reasonably estimate the probability or the estimated range of reasonably possible losses related to material adverse judgments related to such claims and, therefore, we have not accrued for any such judgments. In the future, should we determine that a loss (or an additional loss in excess of our accrual) is at least reasonably possible and material, we would then disclose an estimate of the possible loss or range of loss, if such estimate could be made, or disclose that an estimate could not be made. We believe that we have provided adequate accruals for defense costs.

We ~~have~~ recorded our liability for defense costs before consideration for reimbursement from insurance carriers. We have also recorded the amount due as reimbursement under existing policies from the insurance carriers as a receivable shown in other current assets and other assets.

At this time, an estimated range of reasonably possible additional losses relating to unfavorable outcomes cannot be made.

Commitments

On September 30, 2021, we announced our plan to move our headquarters and significant elements of our operations to Maryville, Tennessee in 2023, or the Relocation. In connection with the Relocation, we entered into a project agreement, or the Project Agreement, with The Industrial Development Board of Blount County and the cities of Alcoa and Maryville, Tennessee, a public, nonprofit corporation organized and existing under the laws of the state of Tennessee, or the IDB. Pursuant to the Project Agreement, we represented to the IDB that we intend to incur, or cause to be incurred, no less than $120.0 million in aggregate capital expenditures on

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and Nine Months Ended January 31, 2023 and 2022

or before December 31, 2025, create no less than 620 new jobs, and sustain an average hourly wage of at least $25.97 at the facility. Further, pursuant to the Project Agreement, we are required to, among other things, (A) execute a facility lease and an equipment lease with the IDB; (B) cause the construction of the new facility at our sole cost and expense to commence on or before May 31, 2022; (C) incur, or cause to be incurred, aggregate capital expenditures in connection with the construction and equipping of the new facility in an aggregate amount of not less than $120.0 million on or before December 31, 2025; (D) cause the construction of the new facility to be substantially completed and for a certificate of occupancy to be issued therefore on or before December 31, 2023; (E) provide the IDB with a written report certified by one of our authorized officers, not later than January 31 of each year during the period between January 31, 2024 and January 31, 2031; and (F) make certain payments to IDB in the event that our actual capital expenditures, number of employees, or average hourly wage of such employees are less than our projections.

~~SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES~~On February 2, 2023, we entered into a design-build agreement with The Christman Company, or Christman, related to the construction of our new distribution center and corporate office headquarters in Maryville, Tennessee, or the Construction Contract. The Construction Contract has an effective date of September 13, 2021 and incorporates the arrangements under which we and Christman have been proceeding. Pursuant to the Construction Contract, Christman is obligated to deliver certain services, including, among others, design phase services and construction phase services, and we are obligated to pay Christman for services performed. The parties to the Construction Contract have jointly agreed that Christman will perform and complete the Work (as defined therein) on a cost plus basis for a guaranteed maximum price of $

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~114,533,853

~~For~~, including contingencies. When adding the ~~Three~~cost of machinery and ~~Six Months Ended October 31, 2022~~equipment, we expect to spend between $160.0 million and ~~2021~~$

170.0 million through the end of fiscal 2024. The Construction Contract includes terms that are customary for contracts of this type, including with respect to indemnification and insurance. The Construction Contract lists certain contract milestones and guaranteed completion dates, and we will be entitled to liquidated damages under certain circumstances. Each party to the Construction Contract is entitled to terminate the Construction Contract under certain circumstances.

As part of the Relocation, on January 31, 2023, we ~~intend to vacate~~entered into the Assignment and ~~sublease our Missouri distribution facility. We have received indications of interest from potential third-party sublessees,~~Assumption Agreement and ~~we believe that we will not incur an impairment~~the Amended and Restated Guaranty. Assets associated with ~~this lease. Assets associated with~~certain of our assembly operations in Massachusetts and distribution operations in Missouri continue to be fully utilized, and we intend to either move those assets to Tennessee at the appropriate time or sell or sublease those assets that will not be moved. Consequently, as of ~~October~~January 31, ~~2022,~~2023, we do not believe we have an impairment related to the building or assets. Subsequent to the Relocation, we expect our Massachusetts facility will continue to remain an important part of our manufacturing activities with significant portions of the operations being unaffected by the Relocation.

In addition, at or near the conclusion of our Connecticut building lease in May 2024, we intend to relocate a portion of our plastic injection molding operations to Tennessee and will evaluate selling the remaining molding operations utilized in our Connecticut operations to a third party. As of ~~October~~January 31, ~~2022,~~2023, all plastic injection molding machinery and equipment was being utilized. Therefore, we could not determine an estimated range of reasonably possible losses associated with any impairment of such assets because we have not yet determined which assets may be sold.

(10) Restructuring:

As a result of the Relocation, $~~3.1~~626,000 ~~million~~ and $~~5.5~~3.0 million of restructuring charges were recorded in the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, respectively, and $~~5.3~~5.9 million and $~~5.5~~8.5 million of restructuring charges were recorded in the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021,~~2022, respectively.

The following table summarizes restructuring charges by line item for the three and ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (in thousands):


	For the Three Months Ended October 31,				For the Six Months Ended October 31,				For the Three Months Ended January 31,					For the Nine Months Ended January 31,
	2022		2021		2022		2021		2023			2022		2023		2022
Cost of sales	$	1,735	$	1,087	$	2,978	$	1,087	$	305		$	1,243	$	3,283	$	2,330
Research and development		—		5		3		5		—			7		3		11
Selling, marketing, and distribution		270		283		707		283		(329	)		638		377		921
General and administrative		1,106		4,173		1,620		4,173		650			1,092		2,271		5,266
Total restructuring charges	$	3,110	$	5,548	$	5,308	$	5,548	$	626		$	2,980	$	5,934	$	8,528

The components of the restructuring charges recorded in our consolidated income statement are as follows (in thousands):


	For the Three Months Ended October 31,				For the Six Months Ended October 31,				For the Three Months Ended January 31,				For the Nine Months Ended January 31,
	2022		2021		2022		2021		2023		2022		2023		2022
Severance and employee-related benefits (a)	$	2,505	$	1,935	$	3,658	$	1,935	$	68	$	2,704	$	4,511	$	4,639
Relocation (a)		179		—		1,062		—		326		36		603		36
Consulting services		206		3,569		266		3,569		91		71		357		3,640
Employee relations		135		44		230		44		57		125		287		169
Office rent and equipment		86		—		92		—		84		44		176		44
Total restructuring charges	$	3,110	$	5,548	$	5,308	$	5,548	$	626	$	2,980	$	5,934	$	8,528

___________________________________________

(a) Accrued under payroll and incentive

The following table summarizes the activity in the severance and employee-related benefits and relocation accruals for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 (in thousands):


	Severance and employee-related benefits		Relocation			Total			Severance and employee-related benefits			Relocation			Total
Accrual at April 30, 2022	$	5,732	$	456		$	6,188		$	5,732		$	456		$	6,188
Charges		3,658		1,062			4,720			3,726			1,388			5,114
Cash payments and settlements		—		(489	)		(489	)		(10	)		(957	)		(967	)
Accrual at October 31, 2022	$	9,390	$	1,029		$	10,419
Accrual at January 31, 2023									$	9,448		$	887		$	10,335

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Please refer to the Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Fiscal 2022 Annual Report and our unaudited condensed consolidated financial statements included in Item 1 of this Quarterly Report on Form 10-Q. This section sets forth key objectives and performance indicators used by us as well as key industry data tracked by us.

Our operating results for the three months ended ~~October~~January 31, ~~2022~~2023 included the following:

Our operating results for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 included the following:

Net Sales and Gross Profit – For the Three Months Ended ~~October~~January 31, ~~2022~~2023

The following table sets forth certain information regarding net sales and gross profit for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Handguns	$	93,037		$	157,525		$	(64,488	)		-40.9	%	$	101,952		$	132,921		$	(30,969	)		-23.3	%
Long Guns		16,999			60,320			(43,321	)		-71.8	%		15,312			29,459			(14,147	)		-48.0	%
Other Products & Services		10,999			12,634			(1,635	)		-12.9	%		11,772			15,358			(3,586	)		-23.3	%
Total net sales	$	121,035		$	230,479		$	(109,444	)		-47.5	%	$	129,036		$	177,738		$	(48,702	)		-27.4	%
Cost of sales		81,773			128,484			(46,711	)		-36.4	%		87,195			107,339			(20,144	)		-18.8	%
Gross profit	$	39,262		$	101,995		$	(62,733	)		-61.5	%	$	41,841		$	70,399		$	(28,558	)		-40.6	%
% of net sales (gross margin)		32.4	%		44.3	%								32.4	%		39.6	%

The following table sets forth certain information regarding firearm units shipped by trade channel for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (units in thousands):


Total Units Shipped	2022		2021		# Change			% Change	2023		2022		# Change			% Change
Handguns		209		383		(174	)	-45.4%		223		316		(93	)	-29.4%
Long Guns		31		109		(78	)	-71.6%		32		55		(23	)	-41.8%

Sporting Goods Channel Units Shipped	2022		2021		# Change			% Change	2023		2022		# Change			% Change
Handguns		191		360		(169	)	-46.9%		207		299		(92	)	-30.8%
Long Guns		27		104		(77	)	-74.0%		30		50		(20	)	-40.0%

Professional Channel Units Shipped	2022		2021		# Change			% Change	2023		2022		# Change			% Change
Handguns		18		23		(5	)	-21.7%		16		17		(1	)	-5.9%
Long Guns		4		5		(1	)	-20.0%		2		5		(3	)	-60.0%

Sales of our handguns decreased ~~$64.5~~$31.0 million, or ~~40.9%~~23.3%, from the comparable quarter last year. The decrease in sales was primarily as a result of a return to more normalized demand from the historic pandemic-related demand that lasted from March 2020 through the beginning of fiscal 2022, partially offset by net sales generated from increased shipments of new products. Handgun unit

shipments into the sporting goods channel decreased by ~~46.9%~~30.8% from the comparable quarter last year while overall consumer handgun demand ~~decreased 7.0%~~increased 1.4% (as indicated by adjusted background checks reported in the National Instant Criminal Background Check System, or ~~NICS).~~adjusted

NICS). The decrease in revenue was primarily due to decreased shipments of our M&P branded polymer pistols, partially offset by increased shipments of revolvers, and increased shipments of newly introduced products, defined as any new SKU not shipped in the comparable quarter last year, which represented 17.0% of sales in the period, as well as two price increases, one of which was across all products and one that was more limited. We believe the decrease in our handgun shipments relative to adjusted NICS was a result of easing consumer demand as competing products became more available subsequent to the pandemic, combined with a trading down in price by consumers due to heightened inflation. In addition, during our third quarter, inventory in our distribution channel declined by an additional 7.6% from our second quarter, or nearly 32.0% lower than the prior year comparable quarter, indicating that our channel partners continue to adjust inventory levels.

Sales of our long guns decreased ~~$43.3~~$14.1 million, or ~~71.8%~~48.0%, from the comparable quarter last year. ~~Similar to handgun sales, this decrease was primarily a result of lower demand for the majority of our long gun products.~~ Long gun unit shipments into our sporting goods channel decreased ~~74.0%~~40.0% from the comparable quarter last year while overall consumer demand for long guns decreased ~~12.1%~~2.7%, as indicated by ~~NICS, reflecting strong continued consumer demand for certain product categories in which we do not currently participate.~~

~~We believe that overall firearm demand remains healthy, as indicated by recent~~ adjusted ~~NICS data, but has normalized from the surge levels we experienced during much~~NICS. Similar to handgun sales, increased competitor activity combined with a decline of ~~calendar 2020 and 2021. We believe~~ our comparable shipments year over year underperformed in comparison to NICS primarily because of channel inventory fluctuations. During the second quarter of fiscal 2022, our inventory in the distribution channel grew significantly (by more than 50%) compared with the second quarter of fiscal 2021. During the second quarter of this current year, however, inventory in our distribution channel ~~declined more~~by an additional 16.6% from our second quarter, or nearly 58% lower than ~~10% compared with~~ the prior year comparable quarter, ~~indicating that our channel partners have continued to adjust inventory levels. We believe this~~ resulted in ~~an outsized swing in our comparable quarterly financial results. Additionally, we believe that~~ our sales ~~were negatively impacted by recent increased aggressive promotional activity by many~~ of ~~our competitors and that~~long guns in the ~~impact of inflation on consumer purchase power resulted in a temporary shift toward lower priced offerings.~~quarter underperforming adjusted NICS results.

Other products and services revenue decreased ~~$1.6~~$3.6 million, or ~~12.9%~~23.3%, from the comparable quarter last year, primarily because of decreased sales of handcuffs, component parts, and business-to-business services, ~~partially offset by increased~~as well as decreased licensing revenue.

New products ~~defined as any new SKU not shipped in the comparable quarter last year,~~ represented ~~25.0%~~20.9% of sales for the three months ended ~~October~~January 31, ~~2022~~2023 and included ~~four~~five new pistols ~~one new modern sporting rifle,~~ and many new product line extensions.

Gross margin for the three months ended ~~October~~January 31, ~~2022~~2023 was 32.4% compared with gross margin of ~~44.3%~~39.6% for the comparable quarter last year, primarily because of a combination of reduced sales volumes across nearly all product lines, the impact of inflation ~~in both~~on raw material and finished parts, which increased approximately 6.0% over the prior year, the impact of inflation on labor costs, particularly as it relates to entry level positions, and ~~labor,~~ unfavorable fixed-cost absorption due to lower production volume, ~~unfavorable product liability adjustments, and unfavorable inventory valuation adjustments,~~ partially offset by decreased compensation ~~costs.~~costs and favorable inventory valuation adjustments. We generally attempt to mitigate inflationary impacts with price increases, when and where possible, based on market dynamics; however, our ability to increase prices in recent periods has been constrained by the competitiveness of the market following the most recent surge in demand. In addition, we generally utilize process improvements to mitigate inflationary impacts; however, our ability to utilize process improvements in recent periods has been constrained by factors related to the Relocation and our ability to utilize process improvements in future periods will likely resume only once the Relocation is completed.

Our inventory balances increased ~~$59.8~~$56.8 million between April 30, 2022 and ~~October~~January 31, ~~2022~~2023 as we replenished stock to provide our customers with a more robust selection of inventory and positioned ourselves for potential increases in consumer demand. During the third quarter of fiscal 2023, our inventory balances decreased $3.0 million. While inventory levels, both internally and in the distribution channel, in excess of demand may negatively impact future operating results, it is difficult to forecast the potential impact of distributor inventories on future revenue and income as demand is impacted by many factors, including seasonality, new product introductions, news events, political events, and consumer tastes. We expect our inventory levels will decline by the end of the fiscal year because of normal seasonality, but will remain elevated as we begin our transition to our new facility in Tennessee.

Net Sales and Gross Profit – For the ~~Six~~Nine Months Ended ~~October~~January 31, ~~2022~~2023

The following table sets forth certain information regarding net sales and gross profit for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Handguns	$	152,403		$	355,381		$	(202,978	)		-57.1	%	$	254,356		$	488,303		$	(233,947	)		-47.9	%
Long Guns		31,105			128,012			(96,907	)		-75.7	%		46,416			157,470			(111,054	)		-70.5	%
Other Products & Services		21,921			21,695			226			1.0	%		33,693			37,053			(3,360	)		-9.1	%
Total net sales	$	205,429		$	505,088		$	(299,659	)		-59.3	%	$	334,465		$	682,826		$	(348,361	)		-51.0	%
Cost of sales		134,696			273,151			(138,455	)		-50.7	%		221,890			380,490			(158,600	)		-41.7	%
Gross profit	$	70,733		$	231,937		$	(161,204	)		-69.5	%	$	112,575		$	302,336		$	(189,761	)		-62.8	%
% of net sales (gross margin)		34.4	%		45.9	%								33.7	%		44.3	%

The following table sets forth certain information regarding firearm units shipped by trade channel for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (units in thousands):


Total Units Shipped									2023		2022		# Change			% Change
Handguns										560		1,205		(645	)	-53.5%
Long Guns										90		301		(211	)	-70.1%

Sporting Goods Channel Units Shipped	2022		2021		# Change			% Change	2023		2022		# Change			% Change
Handguns		307		834		(527	)	-63.2%		514		1,132		(618	)	-54.6%
Long Guns		51		235		(184	)	-78.3%		82		285		(203	)	-71.2%

Professional Channel Units Shipped	2022		2021		# Change			% Change	2023		2022		# Change			% Change
Handguns		30		56		(26	)	-46.4%		46		73		(27	)	-37.0%
Long Guns		7		11		(4	)	-36.4%		8		16		(8	)	-50.0%

Sales of our handguns decreased ~~$203.0~~$233.9 million, or ~~57.1%~~47.9%, from the prior year comparable period. The decrease in sales was primarily as a result of a return to more normalized demand from the historic pandemic-related demand that lasted from March 2020 through the beginning of fiscal 2022 ~~and~~as competing products became more available through the replenishment of depleted channel inventory, partially offset by net sales generated from increased shipments of new ~~products.~~products, which represented 18.6% of sales in the period, and two price increases. Handgun unit shipments into the sporting goods channel decreased by ~~63.2%~~54.6% from the comparable quarter last year while overall consumer handgun demand decreased ~~5.9% (as~~3.4%, as indicated by ~~NICS).~~adjusted NICS. In addition, during the first three quarters of fiscal 2023, inventory in our distribution channel declined by more than 29%, which negatively impacted our net sales for fiscal 2023.

Sales of our long guns decreased ~~$96.9~~$111.1 million, or ~~75.7%~~70.5%, from the prior year comparable period. Similar to handgun sales, this decrease was primarily as a result of lower demand for the majority of our long gun products ~~and~~as competing products became more available through the replenishment of depleted channel inventory. Long gun unit shipments into our sporting goods channel decreased ~~78.3%~~71.2% from the comparable quarter last year while overall consumer demand for long guns decreased ~~8.7%~~6.4%, as indicated by adjusted NICS.

~~As noted above, fiscal 2022 included a period of inventory replenishment, involving significant restocking from the near complete depletion of inventory~~ In addition, during the ~~calendar 2020 and 2021 demand surge. This replenishment~~first three quarters of ~~inventory within the distribution channel peaked in our~~ fiscal third quarter and, since that time, inventory levels have been declining, which has negatively impacted our shipments. During our prior year first half, we saw inventory in our distribution channel grow by more than 400%, while during the current first half,2023, inventory in our distribution channel declined by ~~approximately 25%~~43%, ~~resulting in a significant impact on~~which negatively impacted our net sales for fiscal 2023.

We believe that overall firearm demand remains healthy, as indicated by adjusted NICS data, but has normalized from the surge levels we experienced during much of calendar 2020 and 2021. We believe our comparable ~~financial results.~~shipments year over year underperformed in comparison to adjusted NICS primarily because of an over-replenishment of our channel inventory during the first three quarters of fiscal 2022, at which time channel inventory peaked, and which led to our distribution partners actively seeking to reduce inventory during fiscal 2023.

Other products and services revenue ~~increased $226,000,~~decreased $3.4 million, or ~~1.0%~~9.1%, ~~over~~from the prior year comparable period, primarily because of ~~increased~~decreased sales of component parts, business-to-business services, and ~~handcuffs,~~decreased licensing revenue, partially offset by ~~decreased licensing revenue.~~increased sales of handcuffs.

New products represented ~~23.5%~~22.5% of sales for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and included ~~six~~five new pistols ~~one new modern sporting rifle,~~ and many new product line extensions.

Gross margin for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 was ~~34.4%~~33.7% compared with gross margin of ~~45.9%~~44.3% for the comparable period last year, primarily because of a combination of reduced sales volumes across nearly all product lines, the impact of inflation ~~in both~~on raw material and finished parts, which increased approximately 6.3% over the prior year, the impact of inflation on labor costs, particularly as it relates to entry level positions, and unfavorable fixed-cost absorption due to lower production volume, and expenses ~~recorded~~ related to employee severance, ~~and relocation costs associated with the Relocation, and unfavorable product liability adjustments,~~ partially offset by decreased compensation costs and favorable inventory valuation adjustments. As noted above, we generally attempt to mitigate inflationary impacts with price increases, when and where possible, based on market dynamics, and process improvements, although our ability to utilize process improvements in recent periods has been constrained by factors related to the Relocation.

The following table sets forth certain information regarding operating expenses for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Research and development	$	1,869		$	1,744		$	125			7.2	%	$	2,133		$	1,716		$	417			24.3	%
Selling, marketing, and distribution		9,431			11,423			(1,992	)		-17.4	%		9,996			11,518			(1,522	)		-13.2	%
General and administrative		15,435			23,436			(8,001	)		-34.1	%		15,576			17,443			(1,867	)		-10.7	%
Total operating expenses	$	26,735		$	36,603		$	(9,868	)		-27.0	%	$	27,705		$	30,677		$	(2,972	)		-9.7	%
% of net sales		22.1	%		15.9	%								21.5	%		17.3	%

Research and development expenses increased ~~$125,000~~$417,000 over the prior year comparable quarter, primarily because of new product development costs, partially offset by decreased compensation-related costs, driven by temporarily unfilled positions, which we believe were as a result of the Relocation. Selling, marketing, and distribution expenses decreased ~~$2.0~~$1.5 million, primarily as a result of ~~decreased co-op advertising expenses on lower sales,~~ decreased compensation-related expenses resulting from lower profit-related compensation costs and temporarily unfilled positions, decreased ~~digital~~ advertising costs, decreased co-op advertising expenses on lower sales, and decreased ~~freight~~ costs ~~because of lower shipments,~~associated with the Relocation, partially offset by increased spending on targeted customer promotions and increased ~~radio advertising costs.~~expenses relating to industry shows. General and administrative expenses decreased ~~$8.0~~$1.9 million, primarily because of ~~lower costs associated with the Relocation, decreased legal-related expenses,~~ decreased profit sharing expense, decreased compensation-related costs, driven by temporarily unfilled positions, which we believe were as a result of the Relocation, ~~as well as~~ lower profit-related compensation costs, and ~~decreased bad debt expense.~~lower costs associated with the Relocation.

The following table sets forth certain information regarding operating expenses for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Research and development	$	3,542		$	3,552		$	(10	)		-0.3	%	$	5,675		$	5,269		$	406			7.7	%
Selling, marketing, and distribution		17,458			22,057			(4,599	)		-20.9	%		27,454			33,575			(6,121	)		-18.2	%
General and administrative		33,288			41,049			(7,761	)		-18.9	%		48,867			58,491			(9,624	)		-16.5	%
Total operating expenses	$	54,288		$	66,658		$	(12,370	)		-18.6	%	$	81,996		$	97,335		$	(15,339	)		-15.8	%
% of net sales		26.4	%		13.2	%								24.5	%		14.3	%

Research and development expenses ~~were relatively flat compared with~~increased $406,000 over the prior year comparable period, primarily because of ~~decreased compensation-related~~increased new product development costs, partially offset by ~~new product development~~decreased compensation-related costs. Selling, marketing, and distribution expenses decreased ~~$4.6~~$6.1 million, primarily as a result of decreased compensation-related expenses, decreased co-op advertising expenses, decreased ~~digital~~ advertising costs, and decreased freight costs due to lower shipments, partially offset by ~~increased costs associated with the Relocation,~~ increased spending on targeted customer promotions, and increased expenses related to industry shows. General and administrative expenses decreased ~~$7.8~~$9.6 million, primarily because of decreased profit-related compensation costs, lower costs associated with the Relocation, decreased profit sharing expense, decreased legal-related expenses, ~~decreased compensation-related costs,~~ and decreased bad debt expense.

The following table sets forth certain information regarding operating income for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Operating income from operations	$	12,527		$	65,392		$	(52,865	)		-80.8	%	$	14,136		$	39,722		$	(25,586	)		-64.4	%
% of net sales (operating margin)		10.3	%		28.4	%								11.0	%		22.3	%

Operating income for the three months ended ~~October~~January 31, ~~2022~~2023 decreased ~~$52.9~~$25.6 million from the comparable quarter last year, primarily because of reduced sales volumes across nearly all product lines, unfavorable fixed-cost absorption, ~~unfavorable product liability adjustments, unfavorable inventory valuation adjustments,~~ increased product development costs, ~~and~~ increased costs on targeted customer promotions, and increased expenses related to industry shows, partially offset by decreased co-op advertising expenses, decreased ~~compensation-related~~profit-related compensation expenses, decreased profit sharing expense, decreased digital advertising costs, decreased costs associated with the Relocation, and ~~decreased freight costs due to lower shipments.~~favorable inventory valuation adjustments.

The following table sets forth certain information regarding operating income for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Operating income from operations	$	16,445		$	165,279		$	(148,834	)		-90.1	%	$	30,579		$	205,001		$	(174,422	)		-85.1	%
% of net sales (operating margin)		8.0	%		32.7	%								9.1	%		30.0	%

Operating income for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 decreased ~~$148.8~~$174.4 million from the prior year comparable period, primarily because of reduced sales volumes across nearly all product lines, unfavorable fixed-cost absorption, ~~unfavorable product liability adjustments,~~ increased product development costs, ~~and~~ increased spending on targeted customer promotions, partially offset by decreased co-op advertising expenses, decreased compensation-related expenses, decreased digital advertising costs, decreased freight costs due to lower shipments, decreased profit sharing expense, ~~and~~ decreased legal-related ~~expenses.~~expenses, decreased costs associated with the Relocation, and favorable inventory valuation adjustments.

The following table sets forth certain information regarding income tax expense for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Income tax expense	$	3,249		$	14,824		$	(11,575	)		-78.1	%	$	3,389		$	9,337		$	(5,948	)		-63.7	%
% of income from operations (effective tax rate)		25.2	%		22.5	%					2.6	%		23.4	%		23.4	%					0.0	%

Income tax expense decreased ~~$11.6~~$5.9 million from the comparable quarter last year as a result of lower operating income.

The following table sets forth certain information regarding income tax expense for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):

Income tax expense decreased ~~$33.9~~$39.8 million from the prior year comparable period as a result of lower operating income.

The following table sets forth certain information regarding net income and the related per share data for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands, except per share data):


	2022		2021		$ Change			% Change			2023		2022			$ Change			% Change
Income from operations	$	9,648	$	50,935	$	(41,287	)		-81.1	%	$	11,079	$	30,542	��	$	(19,463	)		-63.7	%
Net income per share
Basic	$	0.21	$	1.06	$	(0.85	)		-80.2	%	$	0.24	$	0.65		$	(0.41	)		-63.1	%
Diluted	$	0.21	$	1.05	$	(0.84	)		-80.0	%	$	0.24	$	0.65		$	(0.41	)		-63.1	%

Net income for the three months ended ~~October~~January 31, ~~2022~~2023 was ~~$9.6~~$11.1 million compared with ~~$50.9~~$30.5 million for the comparable quarter last year for the reasons outlined above.

The following table sets forth certain information regarding net income and the related per share data for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands, except per share data):


	2022		2021		$ Change			% Change			2023		2022		$ Change			% Change
Income from operations	$	12,960	$	127,817	$	(114,857	)		-89.9	%	$	24,039	$	158,359	$	(134,320	)		-84.8	%
Net income per share
Basic	$	0.28	$	2.65	$	(2.37	)		-89.4	%	$	0.52	$	3.32	$	(2.80	)		-84.3	%
Diluted	$	0.28	$	2.63	$	(2.35	)		-89.4	%	$	0.52	$	3.28	$	(2.76	)		-84.1	%

Net income for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 was ~~$13.0~~$24.0 million compared with ~~$127.8~~$158.4 million for the prior year comparable period for the reasons outlined above.

Our principal cash requirements are to (1) finance the growth of our operations, including working capital and capital expenditures, (2) fund the Relocation, and (3) return capital to stockholders. Capital expenditures for the Relocation, new product development, and repair and replacement of equipment represent important cash needs.

The following table sets forth certain cash flow information for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022 (dollars in thousands):


	2022			2021			$ Change			% Change			2023			2022			$ Change			% Change
Operating activities	$	(28,165	)	$	105,364		$	(133,529	)		-126.7	%	$	(21,248	)	$	112,275		$	(133,522	)		-118.9	%
Investing activities		(39,590	)		(10,199	)		(29,391	)		-288.2	%		(64,752	)		(15,211	)		(49,541	)		-325.7	%
Financing activities		(9,998	)		(48,791	)		38,793			79.5	%		9,868			(102,813	)		112,681			109.6	%
Total cash flow	$	(77,753	)	$	46,374		$	(124,127	)		-267.7	%	$	(76,132	)	$	(5,749	)	$	(70,383	)		1224.3	%

On an annual basis, operating activities generally represent the principal source of our cash flows. Cash used in operating activities was ~~$28.2~~$21.2 million for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 compared with ~~$105.4~~$112.3 million of cash generated for the ~~six~~nine months ended ~~October~~January 31, ~~2021.~~2022. In addition to a ~~$114.9~~$134.3 million reduction in net income, cash used in operating activities for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 was negatively impacted by an incremental ~~$18.0 million increase in inventory resulting from lower sales volumes, payment of an incremental $11.3 million in income taxes due to the timing of prior year tax payments, an incremental $4.1~~$12.9 million smaller decrease in accounts receivable, ~~and an incremental $2.6 million increase in prepaid expenses and other current assets. These unfavorable impacts were~~ partially offset by an incremental ~~$14.4~~$21.3 million increase in accounts ~~payable and incremental $6.0 million increase in accrued payroll and incentives due to accruals related to the Relocation.~~payable.

Cash used in investing activities increased ~~$29.4~~$49.5 million for the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 compared with the prior year comparable period. We paid ~~$39.4~~$64.6 million for capital expenditures for the ~~six~~nine months ended ~~October~~January 31, ~~2022, $29.3~~2023, $49.5 million higher than the prior year comparable period primarily due to payments related to the Relocation. Excluding payments related to the Relocation, we expect to spend between $20.0 million and $25.0 million on capital expenditures in fiscal 2023, representing a decrease of $4.0 million to an increase of nearly $1.0 million, as compared with $24.0 million in capital expenditures in fiscal 2022. This is primarily

due to lower expenditures related to capacity offset by expenditures related to new product development and repair and replacement of equipment.

Additionally, as it relates to the Relocation, we expect to incur capital expenditures in connection with the construction and equipping of the new facility in an aggregate amount of ~~not less than $120.0~~approximately $160.0 million ~~on or before December 31, 2025.~~to $170.0 million through the end of fiscal 2024. We expect to spend between ~~$115.0~~$95.0 million and ~~$120.0~~$100.0 million on capital expenditures in fiscal 2023, of which ~~$70.0~~$65.0 million to ~~$75.0~~$70.0 million is expected for the construction of the facility. This spending will be recorded in construction in progress throughout the building construction. Through the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we have incurred ~~$39.8~~$59.3 million and paid ~~$33.0~~$52.8 million for capital expenditures in connection with the Relocation, which was net of $9.0 million in state and local incentives received during the period.

Cash provided by financing activities was $9.9 million for the nine months ended January 31, 2023 compared with $102.8 million used in financing activities ~~was $10.0 million~~ for the ~~six~~nine months ended ~~October~~January 31, ~~2022 compared with $48.8 million for the six months ended October 31, 2021.~~2022. Cash ~~used in~~provided by financing activities during the ~~six~~nine months ended ~~October~~January 31, ~~2022~~2023 was primarily ~~the~~a result of ~~$9.2~~$25.0 million of borrowings under our Revolving Line, partially offset by $13.7 million in dividend distributions. For the ~~six~~nine months ended ~~October~~January 31, ~~2021,~~2022, cash used in financing activities was primarily the result of a ~~$40.0~~$90.0 million treasury stock repurchase and ~~$7.7~~$11.4 million in dividend distributions.

Finance Lease – We are a party to a $46.2 million lease for our Missouri distribution ~~facility,~~center, which has an effective interest rate of approximately 5.0% and is payable in 240 monthly installments through fiscal 2039. The building is pledged to secure the amounts outstanding. During the ~~six~~nine months ending ~~October~~January 31, ~~2022,~~2023, we paid approximately $559,000 in principal payments relating to this finance lease. With the completion of the Separation, we entered into ~~a sublease for 59.0% of this facility under~~ the ~~same terms as the master lease.~~Sublease. On July 16, 2022, we entered into an amendment to the ~~sublease agreement,~~Sublease, increasing the subleased space to 64.7% of the facility under the same terms as the ~~master lease.~~MO Lease. On January 31, 2023, we entered into the Assignment and Assumption Agreement and the Amended and Restated Guaranty.We intend to terminate the Sublease on or around the effective date of the Assignment and Assumption Agreement. For the ~~six~~nine months ended ~~October~~January 31, ~~2022,~~2023, we ~~have~~ recorded ~~$1.1~~$1.7 million of income related to ~~this sublease agreement,~~the Sublease, which is recorded in other income/(expense) in our condensed consolidated statements of income.

Credit Facilities — As of ~~October~~January 31, ~~2022,~~2023, we had no$25.0 million of borrowings outstanding ~~indebtedness. However, we~~on the Revolving Line. We maintain the Revolving Line, which includes availability up to $100.0 million at any one time. The Revolving Line provides for availability for general corporate purposes, with borrowings to bear interest at either the Base Rate or LIBOR rate, plus an applicable margin based on our consolidated leverage ratio, as of ~~October~~January 31, ~~2022.~~2023. The Amended and Restated Credit Agreement also provides a swingline facility in the maximum amount of $5.0 million at any one time (subject to availability under the ~~revolving line)~~Revolving Line). Each Swingline Loan (as defined in the Amended and Restated Credit Agreement) bears interest at the Base Rate, plus an applicable margin based on our consolidated leverage ratio. In the event of a Springing Lien Triggering Event (as defined in the Amended and Restated Credit

Agreement), we would be required to enter into certain documents that create in favor of the administrative agent, and the lenders party to such documents as legal, valid, and enforceable first priority lien on the collateral described therein. Subject to the satisfaction of certain terms and conditions described in the Amended and Restated Credit Agreement, we have an option to increase the Revolving Line by an aggregate amount not exceeding $50.0 million. The Revolving Line matures on the earlier of August 24, 2025, or the date that is six months in advance of the earliest maturity of any Permitted Notes under the Amended and Restated Credit Agreement. We are currently negotiating with our lenders to transition from LIBOR to SOFR, which may affect our future borrowing rates.

The Amended and Restated Credit Agreement contains financial covenants relating to maintaining maximum leverage and minimum debt service coverage. We were in compliance with all debt covenants as of ~~October~~January 31, ~~2022.~~

~~Share Repurchase Programs~~— On March 2, 2021, our Board of Directors authorized the repurchase of up to $100.0 million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. During fiscal 2021, we repurchased 3,380,447 shares of our common stock for $60.0 million under this authorization. During the six months ended October 31, 2021, we completed this stock repurchase program by repurchasing 1,967,420 shares of our common stock for $40.0 million utilizing cash on hand. On June 15, 2021, our Board of Directors authorized the repurchase of an additional $50.0 million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. For the six months ended October 31, 2022, there were no purchases under this authorization; this authorization was completed during fiscal 2022. There were no common stock purchases through the six months ended October 31, 2022, nor were there any unfulfilled authorizations.2023.

Dividends — In March 2022, our Board of Directors authorized a regular quarterly dividend for stockholders of $0.10 per share. The current dividend will be for stockholders of record as of market close on ~~December 20, 2022~~March 16, 2023 and will be payable on ~~January 3,~~March 30, 2023.

Our future capital requirements will depend on many factors, including net sales, the timing and extent of spending to support product development efforts, the expansion of sales and marketing activities, the timing of introductions of new products and enhancements to existing products, the costs to ensure access to adequate manufacturing capacity, and costs related to the Relocation.

Further equity or debt financing may not be available to us on acceptable terms or at all. If sufficient funds are not available or are not available on acceptable terms, our ability to take advantage of unexpected business opportunities or to respond to competitive pressures could be limited or severely constrained.

As of ~~October~~January 31, ~~2022,~~2023, we had ~~$43.0~~$44.6 million in cash and cash equivalents on hand. Based upon our current working capital position, current operating plans, and expected business conditions, we believe that our existing capital resources and credit facilities will be adequate to fund our operations, including our finance leases and other commitments, for the next 12 months.

The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant accounting policies are disclosed in Note 2 of the Notes to the Consolidated Financial Statements in our Fiscal 2022 Annual Report. The most significant areas involving our judgments and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Fiscal 2022 Annual Report, to which there have been no material changes. Actual results could differ from our estimates.

The nature and impact of recent accounting pronouncements, if any, is discussed in Note 2—Basis of Presentation to our condensed consolidated financial statements included elsewhere in this report, which is incorporated herein by reference.

During the period ended ~~October~~January 31, ~~2022,~~2023, we did not enter into or transact any forward option contracts nor did we have any forward contracts outstanding.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of ~~October~~January 31, ~~2022,~~2023, our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act was recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There was no change in our internal control over financial reporting during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

The nature of legal proceedings against us is discussed in Note 9—Commitments and Contingencies to our condensed consolidated financial statements included elsewhere in this report, which is incorporated herein by reference.

As of ~~October~~January 31, ~~2022,~~2023, we had no authorized share repurchase programs.

The exhibits listed on the Index to Exhibits (immediately preceding the signatures section of this Quarterly Report on Form 10-Q) are included herewith or incorporated herein by reference.

* Certain schedules and exhibits have been omitted from this filing pursuant to Instruction 4 to Item 1.01 of Form 8-K. We agree to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Title of each Class	Trading Symbol	Name of exchange on which registered
Common Stock, par value $0.001 per share	SWBI	Nasdaq Global Select Market


PART I - FINANCIAL INFORMATION
	Item 1. Financial Statements (Unaudited)	4
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	1920
	Item 3. Quantitative and Qualitative Disclosures About Market Risk	2526
	Item 4. Controls and Procedures	2527

PART II - OTHER INFORMATION
	Item 1. Legal Proceedings	2628
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	2628
	Item 6. Exhibits	2628
Signatures		2830
EX-31.1
EX-31.2
EX-32.1
EX-32.2


	October 31, 2022		April 30, 2022		January 31, 2023		April 30, 2022
Finished goods	$	119,900	$	58,460	$	112,597	$	58,460
Finished parts		59,523		62,187		62,548		62,187
Work in process		5,472		5,304		6,030		5,304
Raw material		11,579		10,709		12,251		10,709
Total inventories	$	196,474	$	136,660	$	193,426	$	136,660


	October 31, 2022		April 30, 2022		January 31, 2023		April 30, 2022
Accrued employee benefits					$	3,685	$	3,705
Accrued taxes other than income	$	7,349	$	7,008		3,554		7,008
Accrued employee benefits		3,545		3,705
Accrued other		3,514		3,959		3,005		3,959
Accrued distributor incentives		2,694		2,917		2,939		2,917
Accrued professional fees		2,065		1,997		1,975		1,997
Current portion of operating lease obligation						1,596		1,495
Accrued rebates and promotions		1,845		1,243		1,374		1,243
Current portion of operating lease obligation		1,619		1,495
Current portion of finance lease obligation		1,214		1,158		1,243		1,158
Total accrued expenses and deferred revenue	$	23,845	$	23,482	$	19,485	$	23,482


3.1		Amended and Restated Bylaws, dated February 28, 2023 (1)

10.134		Amended and Restated Guaranty, dated January 31, 2021 (2)

10.135		Assignment and Assumption of Lease Agreement, dated January 31, 2023, between Smith & Wesson Sales Company and American Outdoor Brands, Inc. (2)

10.136*		Standard Design-Build Agreement and General Conditions, dated February 2, 2023, between Smith & Wesson Brands, Inc. and The Christman Company (portions of the exhibit have been omitted) (2)

31.1		Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer

31.2		Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer

32.1		Section 1350 Certification of Principal Executive Officer

32.2		Section 1350 Certification of Principal Financial Officer

101.INS		Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Large accelerated filer	☐	Accelerated filer	☒

Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐


	SMITH & WESSON BRANDS, INC. a Nevada corporation

Date: ~~December 6, 2022~~March 9, 2023	By:	/s/ Mark P. Smith
		Mark P. Smith
		President and Chief Executive Officer


Date: ~~December 6, 2022~~March 9, 2023	By:	/s/ Deana L. McPherson
		Deana L. McPherson
		Executive Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary